Data / Form D filings / Ocelot Bio, Inc.
Ocelot Bio, Inc.: Form D filings
Ocelot Bio, Inc., a pharmaceuticals company in San Diego, CA, filed 2 Form D notices with the SEC between 2021 and 2023. The latest, on July 13, 2023, reports $3 million sold of a $12 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 12670 High Bluff Drive, San Diego, CA, 92130
- Phone
- (858) 247-2272
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1856030
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 13, 2023 | New notice | $12,000,000 | $3,000,000 | $9,000,000 | 5 | Jul 6, 2023 | sec.gov |
| Apr 15, 2021 | New notice | $38,000,007 | $36,000,007 | $2,000,000 | 5 | Mar 31, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Camille Samuels | Director | |
| Donald Santel | Director | |
| Jack Nielsen | Director | |
| Katherine Stultz | Executive Officer, Director | |
| Jennifer Schranz | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Jul 10, 2023 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Ocelot Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.